MGMT and glioblastoma: As part of the direct DNA-lesion reversal process, MGMT expression is induced with alkylating agents and serves as an important prognostic marker.42 Clinical trials have demonstrated that MGMT promoter CpG methylation is associated with significantly improved overall survival in primary and recurrent GBM patients.5,43